Latest Gaming News

Fat Prophets Global Contrarian Fund reports a 5.06% rise in pre-tax NTA driven by gains in Japanese and Chinese markets, announcing a special dividend after years of pause.

PointsBet has firmly dismissed Betr Entertainment’s unsolicited scrip takeover proposal, endorsing instead MIXI Australia’s superior all-cash offer. The board highlights significant risks and uncertainties tied to Betr’s bid while unanimously recommending shareholders accept MIXI’s $1.20 per share offer.

Streamplay Studio Limited has posted a positive operating cash flow for the first time since its acquisition-led growth strategy began, buoyed by strong game launches and a new multi-year licensing agreement with Amazon.

Legacy Minerals has initiated a major 10,000-metre diamond drilling program at its Fontenoy Project in NSW, aiming to test newly identified conductive zones linked to platinum group elements, nickel, copper, and gold mineralisation.

BetMakers Technology Group delivered a standout Q4 FY25 with record adjusted EBITDA and improved margins, while announcing a strategic acquisition to deepen its US market presence.

PlaySide Studios has released its unaudited FY25 results, showing revenues just below guidance and an EBITDA loss within expectations amid restructuring. The company remains optimistic about revenue growth and cost savings in FY26, pending the launch of its new title.

Pentanet Limited has secured a $2 million finance facility to fund the final payment for its 5G spectrum licence, reinforcing its growth strategy in telecommunications and cloud gaming.

Lithium Universe has completed the acquisition of New Age Minerals, gaining exclusive rights to a patented solar panel recycling technology that promises to revolutionize critical metal recovery. This move complements its lithium refinery ambitions and positions the company at the forefront of sustainable clean energy solutions.

MIXI Australia has lodged a bidder’s statement for an all-cash $1.20 per share takeover offer for PointsBet Holdings Limited, with the PointsBet Board unanimously recommending acceptance in the absence of a superior proposal.

Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.

SenSen Networks has reported its first full year of positive operating cash flow, driven by strong growth in its Smart Cities segment and strategic cost reductions.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.